Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.63% |
| 2 | Financials | 9.78% |
| 3 | Healthcare | 7.32% |
| 4 | Industrials | 7.25% |
| 5 | Consumer Discretionary | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
WisdomTree US SmallCap Dividend Fund
DES
$2.2B
| $115M | 0.01% |
2,828,155
+64,777
| +2% | +$2.5M |
|
1452
Owens Corning
OC
$11.4B
| $115M | 0.01% |
723,481
-102,397
| -12% | -$12.4M |
|
1453
Tarsus Pharmaceuticals
TARS
$3.07B
| $115M | 0.01% |
1,827,082
-117,190
| -6% | -$7.49M |
|
1454
JPMorgan ActiveBuilders Emerging Markets Equity ETF
JEMA
$1.7B
| $115M | 0.01% |
1,800,049
-1,684,611
| -48% | -$102M |
|
1455
Sun Communities
SUI
$15.2B
| $115M | 0.01% |
957,254
+150,612
| +19% | +$18.8M |
|
1456
Calvert Ultra-Short Investment Grade ETF
CVSB
$269M
| $115M | 0.01% |
2,265,063
+54,905
| +2% | +$2.78M |
|
1457
iShares Morningstar Mid-Cap ETF
IMCB
$1.72B
| $114M | 0.01% |
1,185,395
-323,586
| -21% | -$29.6M |
|
1458
Diodes
DIOD
$4.17B
| $114M | 0.01% |
1,045,681
-618,845
| -37% | -$62.8M |
|
1459
Life Time Group Holdings
LTH
$9.96B
| $114M | 0.01% |
2,801,545
+584,087
| +26% | +$18.5M |
|
1460
Aecom
ACM
$8.43B
| $114M | 0.01% |
1,638,429
-41,040
| -2% | -$3.14M |
|
|
TTAN
1461
ServiceTitan Inc
TTAN
$9.34B
| $114M | 0.01% |
1,612,516
+803,948
| +99% | +$51.8M |
|
1462
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.25B
| $114M | 0.01% |
825,868
+37,999
| +5% | +$4.82M |
|
1463
IES Holdings
IESC
$13.2B
| $113M | 0.01% |
308,442
-46,738
| -13% | -$15.1M |
|
1464
MYR Group
MYRG
$4.82B
| $113M | 0.01% |
226,244
+18,122
| +9% | +$7.44M |
|
1465
Stoke Therapeutics
STOK
$2.1B
| $113M | 0.01% |
3,452,795
+29,515
| +0.9% | +$947K |
|
1466
Community Bank
CBU
$3.29B
| $113M | 0.01% |
1,682,284
-178,802
| -10% | -$11.3M |
|
|
FBCG
1467
Fidelity Blue Chip Growth ETF
FBCG
$7.32B
| $113M | 0.01% |
1,817,581
+243,367
| +15% | +$14.4M |
|
1468
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.48B
| $113M | 0.01% |
5,778,792
-179,273
| -3% | -$3.5M |
|
1469
Acushnet Holdings
GOLF
$5.04B
| $113M | 0.01% |
951,839
-159,722
| -14% | -$15.3M |
|
1470
DigitalOcean
DOCN
$14.3B
| $113M | 0.01% |
717,187
-170,798
| -19% | -$23.1M |
|
1471
VanEck Pharmaceutical ETF
PPH
$997M
| $112M | 0.01% |
1,028,317
+850,470
| +478% | +$88M |
|
1472
Taysha Gene Therapies
TSHA
$1.93B
| $112M | 0.01% |
16,487,479
-1,477,892
| -8% | -$8.75M |
|
1473
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.1B
| $112M | 0.01% |
2,450,023
-693,561
| -22% | -$31.6M |
|
1474
FNB Corp
FNB
$6.54B
| $112M | 0.01% |
5,879,004
+643,809
| +12% | +$11.5M |
|
1475
Takeda Pharmaceutical
TAK
$57.5B
| $112M | 0.01% |
6,994,924
+525,324
| +8% | +$8.69M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.